Status:
UNKNOWN
Regional Midazolam in Quadratus Lumborum Block
Lead Sponsor:
Assiut University
Conditions:
Postoperative Pain
Eligibility:
FEMALE
24-40 years
Phase:
NA
Brief Summary
Midazolam has been used in regional anesthesia of brachial plexus block; it has offered accepted postoperative pain relief. This study will use it in as an adjuvant to bupivacaine 0.25% in quadratus l...
Detailed Description
It is vital to apply adequate postoperative analgesia following Caesarean section (C-section), since it will affect the distinct surgical recovery requirements of the parturient. The ultrasound-guided...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status I or II
- age from 24 to 40 years old
- weight from 50 to 80 kg,
- normal singleton pregnancy with a gestation of at least 37 weeks
Exclusion
- Coagulopathy
- maternal anatomic abnormalities in the block region
- localized infection
- incapable of comprehending or using the verbal rating pain scoring system
- Included medications allergy
- history of chronic pain or regular opioid use.
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 20 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05261672
Start Date
March 15 2022
End Date
January 20 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emad Zarief Kamel Said
Asyut, Egypt, 71111